Today: 9 June 2026
Walmart stock lands in the Nasdaq-100 on Jan. 20 — what investors watch next
10 January 2026
2 mins read

Walmart stock lands in the Nasdaq-100 on Jan. 20 — what investors watch next

New York, January 10, 2026, 07:15 EST — The market has closed.

  • Walmart is set to take AstraZeneca’s spot in the Nasdaq-100 ahead of the market open on Jan. 20.
  • Shares ended Friday roughly 1.3% higher, with investors digesting index flows alongside fresh developments in health and tech sectors.
  • Coming up: U.S. CPI data drops Jan. 13, followed by Walmart’s FY2026 Q4 earnings on Feb. 19.

Walmart Inc (WMT) is set to enter the Nasdaq-100 Index before trading opens on Jan. 20, replacing Britain’s AstraZeneca, Nasdaq announced late Friday. The stock ended the day up 1.3% at $114.53, having fluctuated between $112.06 and $115.46, staying within roughly 2% of its 52-week high. U.S. markets will be closed on Jan. 19 in observance of Martin Luther King Jr. Day.

This reshuffle has real impact since index funds, like ETFs, usually adjust by purchasing newcomers and unloading dropped stocks. Invesco’s QQQ, a major Nasdaq-100 ETF, tracks the Nasdaq-100 and tends to hold those exact stocks.

In November, Walmart announced plans to shift its listing from the New York Stock Exchange to Nasdaq, a move companies typically pitch as a way to cut costs and tap into a tech-savvy investor crowd. The Nasdaq-100 index features giants like Apple and Nvidia.

Walmart introduced Better Care Services this week, an online platform linking customers to third-party urgent care and behavioral health providers, plus access to LillyDirect. The retailer also announced price cuts on over 1,000 wellness items and plans to offer a $15 discount on selected telehealth services starting Jan. 15. “Better Care Services is about making wellness simple and affordable to fit into your life,” said Kevin Host, senior vice president of health and wellness and pharmacy. Walmart News & Leadership

Walmart announced it has appointed Shishir Mehrotra, CEO of Superhuman, to its board, assigning him to the technology and eCommerce committee. Chairman Greg Penner emphasized, “Our focus remains on serving customers through a people-led, tech-powered approach.” Walmart Inc.

Shares climbed into the mid-$115 range on Friday but slipped slightly afterward, ending just below their recent high. Traders will be eyeing whether WMT breaks through that level when markets open Monday, or falls back toward the low-$112 mark.

The macro environment continues to support many consumer stocks. U.S. consumer sentiment edged higher in early January, yet households remain cautious about inflation and jobs, according to a University of Michigan survey released Friday. Survey director Joanne Hsu noted, “They remain guarded about the overall strength of business conditions and labor markets.” Reuters

Tuesday, Jan. 13 at 8:30 a.m. ET brings the U.S. consumer price index for December. CPI figures that deviate from expectations often jolt bond yields and shake up rate forecasts—effects that usually spill over into retail stocks.

Index-driven buying doesn’t change the underlying fundamentals, and these inflows can vanish quickly once the trade gets crowded. Should inflation concerns resurface or price wars heat up, Walmart’s margins might come under pressure despite its push into value and fresh service offerings.

Key upcoming dates include Jan. 20, when the Nasdaq-100 inclusion takes effect, and Feb. 19, when Walmart reports its FY2026 Q4 earnings. The retailer plans to release earnings materials at about 6 a.m. CT, followed by a conference call at 7 a.m. CT.

Stock Market Today

  • Core AI Shares Surge 474% Premarket Amid Market Scrutiny of Filings
    June 9, 2026, 9:33 AM EDT. Core AI Holdings' shares jumped 473.78% premarket to $4.705 on June 9, 2026, despite no new company news. The spike reflects volatile trading in small-cap AI stocks amid a broader tech rally led by Nvidia and others. Core AI, shifting from mobile games to AI infrastructure and data-center ventures, reported 2025 revenue up 58.6% year-on-year but posted net losses and a going-concern warning in its latest filings. Concerns over funding and execution linger despite the company's strategic joint venture with Allianca Group and appointment of industry expert Sonali Garg. Premarket gains could reverse post-market as investors assess long-term viability and cash flow.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results
Previous Story

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut
Next Story

Why Kweichow Moutai Co., Ltd. Class A stock (600519) is in focus: iMoutai restock and a fresh target cut

Go toTop